Shopping Cart
- Remove All
- Your shopping cart is currently empty
HSD17B13-IN-9 (252) acts as an inhibitor of 17β-Hydroxysteroid dehydrogenases (HSD17B13), exhibiting an IC50 of 0.01 μM against 50 nM HSD17B13. It is primarily utilized in research on NAFLD (Nonalcoholic fatty liver diseases) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | HSD17B13-IN-9 (252) acts as an inhibitor of 17β-Hydroxysteroid dehydrogenases (HSD17B13), exhibiting an IC50 of 0.01 μM against 50 nM HSD17B13. It is primarily utilized in research on NAFLD (Nonalcoholic fatty liver diseases) [1]. |
Molecular Weight | 430.44 |
Formula | C22H17F3N2O2S |
Cas No. | 2576690-78-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.